REG - Abbott Laboratories - Statement of changes in beneficial ownership <Origin Href="QuoteRef">ABT.N</Origin>

Abbott LaboratoriesAnnouncement

06/09/2014 20:22

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/Regnews/regnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20140723:nRSW0457Na


RNS Number : 0457N
Abbott Laboratories
22 July 2014 
 
Notification to RNS 
 
Company:         Abbott Laboratories 
 
TIDM: ABT 
 
Headline:          Abbott Laboratories Files Form 4 
 
Abbott Laboratories (the "Company") 
 
22 July 2014 
 
Abbott Laboratories Files Form 4 
 
The Company informs its shareholders that on 22 July 2014, in accordance with
Section 16(a) of the U.S. Securities Exchange Act of 1934, as amended, a Form
4 (the report on Form 4 being a statement of changes in the beneficial
ownership of its officers, directors and 10% owners) ("Form 4") was filed with
the U.S. Securities and Exchange Commission ("SEC"). The Form 4 can be found
on the SEC website at http://www.sec.gov. 
 
A copy of the Form 4 has been submitted to the National Storage Mechanism on
the date of this announcement and is, or will shortly be, available for
inspection at http://www.morningstar.co.uk/uk/NSM. 
 
Issued by: Abbott Laboratories 
 
CONTACT:  Financial, Brian Yoor, +1-847-937-6343, or Tina Ventura,
+1-847-935-9390, or Media, Melissa Brotz, +1-847-935-3456, or Scott Stoffel,
+1-847-936-9502. 
 
This information is provided by RNS
The company news service from the London Stock Exchange